Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116935326 | 11693532 | 6 | F | 20160916 | 20151103 | 20160922 | EXP | PHHY2015BR139180 | NOVARTIS | 0.00 | F | Y | 74.00000 | KG | 20160922 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116935326 | 11693532 | 1 | PS | DIOVAN HCT | HYDROCHLOROTHIAZIDEVALSARTAN | 1 | Oral | VALSARTAN 80 MG AND HYDROCHLOROTHIAZIDE 12.5 MG | Y | 1521531 | 20818 | 1 | DF | TABLET | |||||
| 116935326 | 11693532 | 2 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF(80 MG), QD | 0 | 1 | DF | TABLET | QD | ||||||
| 116935326 | 11693532 | 3 | SS | DIOVAN | VALSARTAN | 1 | Oral | 1 DF (160 MG), QD (1 TABLET IN THE MORNING AND 1 AT NIGHT) | 0 | 1 | DF | TABLET | QD | ||||||
| 116935326 | 11693532 | 4 | SS | DIOVAN | VALSARTAN | 1 | Oral | 2 DF (160 MG), QD (1 TABLET IN THE MORNING AND 1 AT NIGHT) | 0 | 2 | DF | TABLET | QD | ||||||
| 116935326 | 11693532 | 5 | C | GLIFAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 2 DF, QD (2 TAB AT NIGHT ) | 0 | 2 | DF | TABLET | QD | ||||||
| 116935326 | 11693532 | 6 | C | CLINFOL | 2 | Oral | 1 DF, QD (1 TAB AT NIGHT) | 0 | 1 | DF | TABLET | QD | |||||||
| 116935326 | 11693532 | 7 | C | CLINFAR | SIMVASTATIN | 1 | Oral | 1 DF, QD (01 TB AT NIGHT) (STARTED 3 YEARS AGO) | 0 | 20 | MG | QD | |||||||
| 116935326 | 11693532 | 8 | C | EUTHYROX | LEVOTHYROXINE SODIUM | 1 | Oral | 125 MG, QD (STARTED 2 MONTHS AGO) | 0 | 125 | MG | TABLET | QD | ||||||
| 116935326 | 11693532 | 9 | C | CLIFAR | 2 | Unknown | STARTED 3 YEARS AGO | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116935326 | 11693532 | 1 | Hypertension |
| 116935326 | 11693532 | 2 | Hypertension |
| 116935326 | 11693532 | 5 | Blood glucose increased |
| 116935326 | 11693532 | 6 | Blood cholesterol abnormal |
| 116935326 | 11693532 | 7 | Blood cholesterol abnormal |
| 116935326 | 11693532 | 8 | Hypothyroidism |
| 116935326 | 11693532 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116935326 | 11693532 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116935326 | 11693532 | Blood cholesterol increased | |
| 116935326 | 11693532 | Blood pressure increased | |
| 116935326 | 11693532 | Depression | |
| 116935326 | 11693532 | Diabetes mellitus | |
| 116935326 | 11693532 | Gastric cancer | |
| 116935326 | 11693532 | Gastrointestinal disorder | |
| 116935326 | 11693532 | Headache | |
| 116935326 | 11693532 | Insomnia | |
| 116935326 | 11693532 | Malabsorption | |
| 116935326 | 11693532 | Pain | |
| 116935326 | 11693532 | Tension | |
| 116935326 | 11693532 | Thyroid neoplasm | |
| 116935326 | 11693532 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 116935326 | 11693532 | 1 | 201510 | 0 |